News
Why Shares of Fulgent Genetics Nearly Doubled in 2021
Shares of diagnostic testing company Fulgent Genetics (NASDAQ: FLGT) were up 93% last year, according to S&P Global Market Intelligence. The unpredictability of COVID took shareholders on a journey
Why Shares of Teladoc Sank in 2021
Shares of virtual healthcare provider Teladoc Health (NYSE: TDOC) fell 54% last year, according to data provided by S&P Global Market Intelligence. The performance is especially painful in a year in
Why Bill.com Shares Fell 11% in December
Shares of Bill.com Holdings (NYSE: BILL) dropped 11% in December by no fault of their own. The company didn't have any major news last month, but its stock was another victim of investors bailing
Welcome to Earnings Season: Here's What's to Expect
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
Was last week —
Attendance Down 70% at the Tech Industry's Biggest Gadget Show
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
One of the
EU Contemplates Rule Changes Amid Wave Of "Ghost Flights"
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
Remember the
Here's Why Walgreens Stock Jumped 16.4% in December
Shares of Walgreens Boots Alliance (NASDAQ: WBA) rose 16.4% last month as investors favored healthcare stocks and other defensive industries. There wasn't any major news about Walgreens in December
Why Shares of SolarEdge Technologies Plummeted 14% in December
Failing to recover from its 7.6% decline in November, shares of SolarEdge Technologies (NASDAQ: SEDG) plunged 14.4% in the last month of 2021, according to data from S&P Global Market Intelligence.
My 3 Top Biotech Stock Picks for 2022
Biotech stocks haven't been at their best of late. The SPDR S&P Biotech Exchange Traded Fund (NYSEMKT: XBI) has lost more than 30% of its value over the prior 12 months. The XBI is thus bumping up
Why Tesla Shares Jumped 50% Last Year
2021 was a rough year for many manufacturers, as businesses were forced to navigate cost increases and supply chain constraints. Electric-vehicle (EV) leader Tesla (NASDAQ: TSLA) handled those
Why Sherwin-Williams' Shares Soared 43% Higher in 2021
Sherwin-Williams (NYSE: SHW), the world's largest paint and coatings company, saw its shares rise 43% in 2021, according to data from S&P Global Market Intelligence. The stock began 2020 at $245 a
That Rumble You Heard Was CF Acquisition Corp. VI Soaring 10% in December
Particularly during President Trump's administration, conservatives charged Big Tech with conspiring to silence their voices by either changing their algorithms to shadow ban them or outright
Why Roblox Rolled Over for an 18% Loss in December
Shares of Roblox (NYSE: RBLX) tumbled like a Jenga tower, after the online gaming platform reported November metrics that were below expectations. According to data from S&P Global Market
Why Gores Guggenheim Stalled Out With a 13% Drop in December
The electric-vehicle (EV) market got overheated in 2021, but it cooled considerably as the year wore on, which explains why Gores Guggenheim (NASDAQ: GGPI), a special-purpose acquisition company (SP
My 3 Top Biopharma Stock Picks for 2022
Thanks to the dual headwinds of sky-high inflation and the threat of rising interest rates, biopharmaceutical stocks appear poised for a turbulent 2022. Underscoring this point, investors have been
3 Top Software Stocks to Buy for the Long Haul
Our daily lives revolve around software. Whether at home, work, or play, software is likely to play a vital role in our activities. Due to annual recurring revenues (ARR), profitability, and high
3 No-Brainer Big Pharma Stocks to Buy in 2022
Going big can sometimes pay off. That's especially the case when you invest in the stocks of top large drugmakers.
We asked three Motley Fool contributors to identify the big pharma stocks that
3 Top Energy Dividend Stocks to Buy in January
The energy industry is coming off its best year in quite some time. Higher oil and gas prices fueled some big-time gains across the sector last year. The improving market conditions have also
Boeing Rings Up 3 Orders as Calendar Flips to 2022
In 2021, Boeing (NYSE: BA) continued to lose money and burn cash, weighing on the company's shares. That said, the aerospace giant's performance did improve in one respect last year, as order
Better Buy: Federal Realty Investment Trust vs. Realty Income
Federal Realty Investment Trust (NYSE: FRT) and Realty Income (NYSE: O) have a lot in common that commends them to investors as long-term buy and holds.
They're both real estate investment trusts
This Crypto Might Be the Solana of 2022
Fantom (CRYPTO: FTM) is under the radar right now, but probably not for long. The crypto had an amazing run-up last year. The coin sold for $0.02 a year ago. Now it's trading at $3 a coin.
Fantom is
What Will the Fed's 2022 Taper Plans Mean for Social Security?
Social Security's Trust Funds currently have just over $2.8 trillion in assets in them, yet those funds are expected to run dry by 2034, which would cut benefits by nearly a quarter. A key reason
My Favorite Warren Buffett Stock to Buy for 2022
Legendary investor Warren Buffett is one of the best stock pickers of all time. His stock picks are available for everyone to view every quarter when his holding company, Berkshire Hathaway (NYSE:
Trulieve Stock in 2022: Skyrocket or Crash?
One of the most frustrating trades of 2021 was in U.S. cannabis stocks. After riding a wave of enthusiasm early in the year on the back of a Democratic electoral victory and hopes for federal
3 Unstoppable Growth Stocks to Buy in 2022 and Beyond
It is always a good idea to not put all your eggs in one basket. Diversification in investing is beneficial for the portfolio. Choosing growth stocks from different sectors will keep one's portfolio